JYHB2400115 | 白消安注射液 | busulfan | Injection | Chemical Drugs(5.1) | Supplementary Application | 2024-03-06 | | Baxter Oncology GmbH;Otsuka Pharmaceutical Co Ltd | | | view |
JYHZ2200263 | 白消安注射液 | busulfan | Injection | Chemical Drugs(5.1) | License Renew | 2022-09-29 | | Baxter Oncology GmbH;Otsuka Pharmaceutical Co Ltd | | | view |
CYHS2301987 | 白消安注射液 | busulfan | Injection | Chemical Drugs(4) | Generic Drug | 2023-07-25 | | Guangdong Zorun Pharmaceutical Research and Develop Co Ltd;Sichuan Meida Kangjiale Pharmaceutical Co Ltd | | | view |
JYHB2101614 | 白消安注射液 | busulfan | Injection | Chemical Drugs | Supplementary Application | 2021-12-23 | | Baxter Oncology GmbH;Otsuka Pharmaceutical Co Ltd | | | view |
JYHZ1400444 | 白消安片 | busulfan | Tablet | Chemical Drugs | License Renew | 2014-07-16 | | Aspen Pharmacare Australia Pty Ltd;Excella GmbH | Certificate Issued | 2015-05-22 | view |
CYHS2201284 | 白消安注射液 | busulfan | Injection | Chemical Drugs(4) | Generic Drug | 2022-08-11 | | Zhe JIANG HUA HAI Pharmaceutical Co Ltd | | | view |
JYHZ2500002 | 白消安片 | busulfan | Tablet | Chemical Drugs | License Renew | 2025-01-07 | | Excella GmbH;Aspen Pharmacare Australia Pty Ltd | | | view |
J0301152 | 白消安片 | busulfan | Tablet | Chemical Drugs | Supplementary Application | 2003-12-24 | | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2004-03-10 | view |
CYHB2350476 | 白消安注射液 | busulfan | Injection | Chemical Drugs(原6) | Supplementary Application | 2023-06-07 | | China Resources Double-Crane Pharmaceutical Co Ltd | | | view |
JYHB2101613 | 白消安注射液 | busulfan | Injection | Chemical Drugs | Supplementary Application | 2021-12-23 | | Baxter Oncology GmbH;Otsuka Pharmaceutical Co Ltd | | | view |
JYHB2400116 | 白消安注射液 | busulfan | Injection | Chemical Drugs(5.1) | Supplementary Application | 2024-03-06 | | Baxter Oncology GmbH;Otsuka Pharmaceutical Co Ltd | | | view |
JYHZ2200264 | 白消安注射液 | busulfan | Injection | Chemical Drugs(5.1) | License Renew | 2022-09-29 | | Baxter Oncology GmbH;Otsuka Pharmaceutical Co Ltd | | | view |
J0301712 | 白消安片 | busulfan | Tablet | Chemical Drugs | License Renew | 2003-12-10 | Glaxo SmithKline Australia Pty Ltd | Glaxo Smithkline Australia Pty Ltd;GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2004-06-21 | view |
JYHB0900311 | 白消安注射液 | busulfan | Injection | Chemical Drugs | Supplementary Application | 2009-04-29 | Otsuka Pharmaceutical Company,Ltd. | Otsuka Pharmaceutical Company Ltd;Ben Venue Laboratories Inc | Certificate Issued | 2009-09-27 | view |
CYHS1800430 | 白消安注射液 | busulfan | Injection | Chemical Drugs(4) | Generic Drug | 2018-11-23 | 健进制药有限公司 | Sagent (China) Pharmaceuticals Co Ltd | Certificate Issued | 2021-01-21 | view |
JYHB1800269 | 白消安片 | busulfan | Tablet | Chemical Drugs | Supplementary Application | 2018-04-04 | 凯顺富达(北京)生物科技有限公司 | Kaishun Fuda (Beijing) Biotechnology Co Ltd;Excella GmbH;Aspen Pharmacare Australia Pty Ltd | Certificate Issued | 2020-07-15 | view |
JYHZ1900304 | 白消安片 | busulfan | Tablet | Chemical Drugs | License Renew | 2020-01-16 | 凯顺富达(北京)生物科技有限公司 | Kaishun Fuda (Beijing) Biotechnology Co Ltd;Excella GmbH;Aspen Pharmacare Australia Pty Ltd | Certificate Issued | 2020-07-14 | view |
CYHS1400996 | 白消安注射液 | busulfan | Injection | Chemical Drugs(6) | Generic Drug | 2014-12-03 | 华润双鹤药业股份有限公司 | China Resources Double-Crane Pharmaceutical Co Ltd | Certificate Issued | 2018-05-30 | view |
CYHS1001099 | 白消安 | busulfan | Active ingredient | Chemical Drugs(6) | Generic Drug | 2011-03-03 | 四川科瑞德凯华制药有限公司 | Luzhou Credit Pharmaceutical Co Ltd | Certificate Issued | 2013-01-10 | view |
JYHB2000802 | 白消安注射液 | busulfan | Injection | Chemical Drugs | Supplementary Application | 2020-06-11 | 浙江大冢制药有限公司 | Zhejiang Otsuka Pharmaceutical Co Ltd;Baxter Oncology GmbH;Otsuka Pharmaceutical Co Ltd | Filed | 2020-06-19 | view |